S&P 500 and the Dow futures rose on Thursday on hopes for a swift roll-out of a COVID-19 vaccine. The boost took the focus off a report that is likely
People with a significant history of allergies should not receive Pfizer Inc. (NYSE:PFE) and BioNTech SE’s (NASDAQ:BNTX) Covid-19 vaccine. This was a statement from the U.K.’s National Health Service, after
U.S. stocks will open lower on Tuesday, as investors weigh the rising numbers of Covid-19 cases. They are considering the associated lockdowns with a vaccine rollout and potential fiscal stimulus.
U.S. stocks were lower on Monday, consolidating after record gains. The Covid-19 surge prompts further lockdowns as virus cases grow. The Dow Futures contract fell 101 points, or 0.3% at